Cannabis regulators in Colorado are looking at changing how marijuana products are sampled for lab testing after concerns that the current system makes it too easy to game the results.
Right now, companies can select which products get sent in for testing — a setup critics say invites “cherry-picking” the cleanest batches while less pristine inventory ends up on shelves. Officials are weighing a shift that would require independent collectors or labs to pull samples themselves, cutting out that discretion.
The discussion follows years of enforcement issues tied to sampling practices, including cases where tested material didn’t match what consumers actually bought or where results were manipulated through questionable treatments. Industry complaints and regulatory data have pushed the issue into sharper focus.
Supporters argue independent sampling would improve transparency and restore trust in potency and safety labels. Skeptics warn tighter oversight could increase compliance costs — and ultimately push prices higher.
Dabbin-Dad Newsroom
